| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.695 | 0.009 | 0.695 | Angiogenesis inhibitor | |||
| 0.637 | 0.009 | 0.767 | Immunosuppressant | 0.767 0.004 DBMET00226 | DBMET00226 | |
| 0.629 | 0.005 | 0.629 | Tyrosine-protein kinase receptor FLT3 inhibitor | |||
| 0.656 | 0.039 | 0.846 | Antiinflammatory | 0.846 0.01 DBMET00226 | DBMET00226 | |
| 0.613 | 0.005 | 0.613 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.388 0.112 DBMET00226 | ||
| 0.502 | 0.024 | 0.502 | Aryl hydrocarbon receptor agonist | |||
| 0.411 | 0.002 | 0.67 | Dihydroorotase inhibitor | 0.67 0.001 DBMET00226 | DBMET00226 | |
| 0.4 | 0.019 | 0.4 | Transcription factor STAT inhibitor | |||
| 0.394 | 0.018 | 0.394 | EphB2 antagonist | |||
| 0.343 | 0.004 | 0.343 | Nav1.8 sodium channel blocker | |||
| 0.332 | 0.005 | 0.332 | Macrophage colony-stimulating factor 1 receptor antagonist | |||
| 0.334 | 0.007 | 0.334 | Sodium channel blocker | |||
| 0.406 | 0.087 | 0.406 | Cyclophilin D inhibitor | |||
| 0.327 | 0.015 | 0.327 | Protein-tyrosine kinase Lyn inhibitor | |||
| 0.319 | 0.012 | 0.319 | Growth factor agonist | |||
| 0.296 | 0.005 | 0.296 | Raf kinase C inhibitor | |||
| 0.286 | 0.004 | 0.286 | TRPA1 antagonist | 0.062 0.04 DBMET00226 | ||
| 0.275 | 0.009 | 0.275 | ATPase inhibitor | |||
| 0.266 | 0.012 | 0.266 | Granulocyte macrophage colony stimulating factor antagonist | |||
| 0.339 | 0.092 | 0.339 | Calpain 2 inhibitor | |||
| 0.273 | 0.027 | 0.273 | Neurotrophic factor enhancer | 0.213 0.065 DBMET00226 | ||
| 0.246 | 0.006 | 0.246 | Stem cell growth factor agonist | |||
| 0.362 | 0.125 | 0.362 | Transcription factor inhibitor | 0.215 0.214 DBMET00226 | ||
| 0.27 | 0.038 | 0.27 | Neuropeptide Y2 antagonist | 0.234 0.073 DBMET00226 | ||
| 0.343 | 0.121 | 0.343 | 5 Hydroxytryptamine release inhibitor | 0.342 0.122 DBMET00226 | ||
| 0.235 | 0.018 | 0.235 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | |||
| 0.206 | 0.004 | 0.652 | Dihydroorotate dehydrogenase inhibitor | 0.652 0.002 DBMET00226 | DBMET00226 | |
| 0.208 | 0.006 | 0.208 | Transcription factor STAT6 inhibitor | |||
| 0.347 | 0.148 | 0.425 | Caspase 9 stimulant | 0.425 0.096 DBMET00226 | DBMET00226 | |
| 0.217 | 0.024 | 0.217 | Sodium channel (voltage-gated) blocker | |||
| 0.229 | 0.049 | 0.229 | Nitric-oxide synthase stimulant | |||
| 0.232 | 0.053 | 0.287 | MAP kinase kinase 3 inhibitor | 0.287 0.01 DBMET00226 | DBMET00226 | |
| 0.218 | 0.046 | 0.218 | Histone acetyltransferase inhibitor | |||
| 0.162 | 0.003 | 0.162 | Calcium release-activated channel blocker | |||
| 0.256 | 0.102 | 0.256 | Nootropic | |||
| 0.218 | 0.074 | 0.218 | Antimitotic | |||
| 0.288 | 0.148 | 0.381 | MAP kinase kinase 6 inhibitor | 0.381 0.07 DBMET00226 | DBMET00226 | |
| 0.182 | 0.044 | 0.182 | Vascular endothelial growth factor antagonist | |||
| 0.161 | 0.024 | 0.161 | Potassium channel (Ca-activated) activator | 0.084 0.071 DBMET00226 | ||
| 0.175 | 0.041 | 0.175 | Vascular endothelial growth factor 2 antagonist | |||
| 0.136 | 0.005 | 0.136 | Glutamate (mGluR group III) agonist | |||
| 0.188 | 0.059 | 0.188 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.139 | 0.013 | 0.139 | Epoxide hydrolase inhibitor | |||
| 0.265 | 0.141 | 0.265 | GABA C receptor rho-3 antagonist | |||
| 0.142 | 0.023 | 0.142 | Interleukin 2 antagonist | |||
| 0.124 | 0.005 | 0.124 | Potassium channel (Tandem pore domain) blocker | 0.07 0.062 DBMET00226 | ||
| 0.142 | 0.025 | 0.142 | Androgen antagonist | 0.115 0.036 DBMET00226 | ||
| 0.15 | 0.039 | 0.15 | Death-associated protein kinase 1 inhibitor | |||
| 0.166 | 0.056 | 0.166 | Lck kinase inhibitor | |||
| 0.173 | 0.064 | 0.173 | Death-associated protein kinase 2 inhibitor | 0.155 0.094 DBMET00226 | ||
| 0.13 | 0.023 | 0.13 | Potassium channel (Voltage-sensitive) activator | 0.097 0.057 DBMET00226 | ||
| 0.147 | 0.042 | 0.147 | Vascular endothelial growth factor 1 antagonist | |||
| 0.134 | 0.033 | 0.134 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | |||
| 0.229 | 0.133 | 0.569 | Immunomodulator | 0.569 0.015 DBMET00226 | DBMET00226 | |
| 0.105 | 0.011 | 0.105 | Aryl hydrocarbon receptor antagonist | |||
| 0.119 | 0.025 | 0.119 | Raf kinase inhibitor | |||
| 0.149 | 0.063 | 0.16 | Sphingosine 1-phosphate receptor 5 antagonist | 0.16 0.046 DBMET00226 | DBMET00226 | |
| 0.099 | 0.019 | 0.099 | Secretase beta inhibitor | |||
| 0.162 | 0.083 | 0.162 | Tyrosine kinase inhibitor | 0.12 0.108 DBMET00226 | ||
| 0.109 | 0.032 | 0.109 | Glutamate receptor agonist | |||
| 0.1 | 0.024 | 0.1 | Potassium channel large-conductance Ca-activated activator | 0.063 0.055 DBMET00226 | ||
| 0.11 | 0.034 | 0.11 | Platelet growth factor antagonist | |||
| 0.104 | 0.034 | 0.104 | GABA A receptor agonist | |||
| 0.09 | 0.021 | 0.09 | Orexin receptor 1 antagonist | |||
| 0.118 | 0.05 | 0.118 | Multidrug resistance-associated protein 1 inhibitor | |||
| 0.122 | 0.054 | 0.122 | GABA receptor agonist | |||
| 0.088 | 0.02 | 0.088 | Orexin receptor antagonist | |||
| 0.118 | 0.057 | 0.118 | Nav1.5 sodium channel blocker | |||
| 0.074 | 0.014 | 0.807 | Dihydroorotate oxidase inhibitor | 0.807 0 DBMET00226 | DBMET00226 | |
| 0.104 | 0.044 | 0.186 | Potassium channel activator | 0.186 0.011 DBMET00226 | DBMET00226 | |
| 0.145 | 0.086 | 0.145 | CF transmembrane conductance regulator agonist | |||
| 0.076 | 0.021 | 0.076 | Bromodomain-containing protein 4 inhibitor | |||
| 0.066 | 0.016 | 0.066 | CXC chemokine 1 receptor antagonist | |||
| 0.096 | 0.059 | 0.096 | Bile acid receptor antagonist | |||
| 0.061 | 0.025 | 0.061 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.111 | 0.076 | 0.111 | Beta amyloid protein antagonist | |||
| 0.081 | 0.046 | 0.081 | Vanilloid antagonist | |||
| 0.233 | 0.199 | 0.233 | Analgesic | |||
| 0.05 | 0.016 | 0.05 | Nicotinic receptor beta4 subunit antagonist | |||
| 0.07 | 0.036 | 0.07 | NMDA receptor agonist | |||
| 0.115 | 0.082 | 0.115 | Sphingosine 1-phosphate receptor 4 antagonist | 0.115 0.082 DBMET00226 | ||
| 0.057 | 0.024 | 0.057 | Nicotinic receptor alpha4 subunit antagonist | |||
| 0.053 | 0.021 | 0.053 | Benzodiazepine inverse agonist | |||
| 0.049 | 0.018 | 0.049 | Growth hormone secretagogue receptor antagonist | |||
| 0.072 | 0.042 | 0.072 | Vanilloid 1 antagonist | |||
| 0.054 | 0.025 | 0.054 | CC chemokine receptor 2B antagonist | |||
| 0.076 | 0.048 | 0.076 | Histone deacetylase stimulant | |||
| 0.076 | 0.048 | 0.076 | Histone deacetylase SIRT1 stimulant | |||
| 0.117 | 0.089 | 0.117 | Interleukin 4 antagonist | |||
| 0.096 | 0.068 | 0.096 | Insulin receptor antagonist | |||
| 0.05 | 0.024 | 0.05 | Stearoyl-CoA desaturase inhibitor | |||
| 0.033 | 0.008 | 0.033 | Glucosylceramidase stimulant | |||
| 0.063 | 0.038 | 0.063 | Raf kinase B inhibitor | |||
| 0.034 | 0.009 | 0.034 | Urotensin II antagonist | |||
| 0.084 | 0.059 | 0.084 | Bcr-Abl kinase inhibitor | 0.079 0.066 DBMET00226 | ||
| 0.069 | 0.045 | 0.069 | Glutamate (mGluR7) antagonist | |||
| 0.103 | 0.081 | 0.103 | CDK3/cyclin E inhibitor | |||
| 0.043 | 0.021 | 0.043 | Delayed rectifier potassium channel activator | |||
| 0.043 | 0.021 | 0.043 | Potassium channel KCNQ activator | |||
| 0.06 | 0.038 | 0.06 | Ca(v)3.2 blocker | |||
| 0.083 | 0.062 | 0.083 | Ca(v)2.2 blocker | |||
| 0.036 | 0.016 | 0.036 | Vanilloid 4 antagonist | |||
| 0.033 | 0.017 | 0.033 | Purinergic P2Y14 antagonist | 0.029 0.023 DBMET00226 | ||
| 0.074 | 0.058 | 0.074 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.028 | 0.012 | 0.028 | Glutamate (mGluR1) agonist | |||
| 0.039 | 0.024 | 0.044 | Potassium channel Kv1.1 blocker | 0.044 0.018 DBMET00226 | DBMET00226 | |
| 0.091 | 0.077 | 0.091 | GABA C receptor agonist | |||
| 0.056 | 0.041 | 0.056 | Pregnane X receptor antagonist | |||
| 0.117 | 0.103 | 0.117 | Cyclooxygenase inhibitor | |||
| 0.049 | 0.035 | 0.049 | Bromodomain-containing protein 3 inhibitor | |||
| 0.032 | 0.019 | 0.032 | Potassium channel subfamily K member 3 blocker | |||
| 0.019 | 0.008 | 0.019 | Microsomal triglyceride transfer protein inhibitor | |||
| 0.035 | 0.026 | 0.035 | Orexin receptor 2 antagonist | |||
| 0.026 | 0.019 | 0.026 | CXC chemokine 2 receptor antagonist | |||
| 0.041 | 0.035 | 0.041 | Neurokinin 3 antagonist | |||
| 0.056 | 0.05 | 0.056 | Purinergic P2X1 antagonist | |||
| 0.023 | 0.018 | 0.023 | Epoxide hydrolase 2 inhibitor | |||
| 0.056 | 0.052 | 0.056 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.052 | 0.048 | 0.052 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.046 | 0.042 | 0.046 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.231 | 0.228 | 0.361 | Calcium channel L-type activator | 0.361 0.109 DBMET00226 | DBMET00226 | |
| 0.115 | 0.112 | 0.115 | Src kinase inhibitor | |||
| 0.017 | 0.015 | 0.017 | Apolipoprotein B-100 inhibitor | |||
| 0.088 | 0.087 | 0.088 | Carbonic anhydrase XV inhibitor | |||
| 0.052 | 0.051 | 0.052 | Calcium channel T-type blocker | |||
| 0.061 | 0.062 | 0.067 | Prostaglandin-E synthase inhibitor | 0.067 0.053 DBMET00226 | DBMET00226 | |
| 0.045 | 0.047 | 0.056 | Potassium channel (Inward rectifier) activator | 0.056 0.025 DBMET00226 | DBMET00226 | |
| 0.043 | 0.045 | 0.053 | Potassium channel (ATP-sensitive) activator | 0.053 0.024 DBMET00226 | DBMET00226 | |
| 0.016 | 0.021 | 0.019 | Potassium channel (Inward rectifier) 11 blocker | 0.019 0.01 DBMET00226 | DBMET00226 | |
| 0.127 | 0.135 | 0.134 | Ca2+-transporting ATPase inhibitor | 0.134 0.1 DBMET00226 | DBMET00226 | |
| 0.032 | 0.041 | 0.052 | Dihydropteroate synthase inhibitor | 0.052 0.015 DBMET00226 | DBMET00226 | |
| 0.054 | 0.068 | 0.068 | Heme oxygenase stimulant | 0.068 0.029 DBMET00226 | DBMET00226 | |
| 0.11 | 0.126 | 0.139 | Sphingosine 1-phosphate receptor 2 antagonist | 0.139 0.057 DBMET00226 | DBMET00226 | |
| 0.082 | 0.131 | 0.142 | Bone formation stimulant | 0.142 0.066 DBMET00226 | DBMET00226 | |
| 0.053 | 0.103 | 0.066 | Exportin-1 inhibitor | 0.066 0.054 DBMET00226 | DBMET00226 | |
| 0.034 | 0.088 | 0.082 | NMDA receptor glycine site agonist | 0.082 0.027 DBMET00226 | DBMET00226 | |
| 0.017 | 0.073 | 0.124 | Estrogen-related receptor alpha antagonist | 0.124 0.005 DBMET00226 | DBMET00226 | |
| 0.064 | 0.133 | 0.143 | Ferrochelatase inhibitor | 0.143 0.041 DBMET00226 | DBMET00226 | |
| 0.015 | 0.086 | 0.031 | Cholesterol ester transfer protein antagonist | 0.031 0.022 DBMET00226 | DBMET00226 | |
| 0.157 | 0.238 | 0.308 | Insulysin inhibitor | 0.308 0.054 DBMET00226 | DBMET00226 | |
| 0.031 | 0.117 | 0.067 | Androgen agonist | 0.067 0.033 DBMET00226 | DBMET00226 | |
| 0.104 | 0.204 | 0.201 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.201 0.099 DBMET00226 | DBMET00226 | |
| 0.032 | 0.136 | 0.128 | Catalase inhibitor | 0.128 0.031 DBMET00226 | DBMET00226 | |
| 0.034 | 0.138 | 0.06 | Transcription factor AP-1 inhibitor | 0.06 0.045 DBMET00226 | DBMET00226 | |
| 0.06 | 0.169 | 0.104 | Histone deacetylase class III inhibitor | 0.104 0.086 DBMET00226 | DBMET00226 | |
| 0.155 | 0.264 | 0.233 | DNA polymerase beta inhibitor | 0.233 0.203 DBMET00226 | DBMET00226 | |
| 0.131 | 0.243 | 0.159 | MAP kinase kinase 5 inhibitor | 0.159 0.119 DBMET00226 | DBMET00226 | |
| 0.065 | 0.181 | 0.167 | Alpha-N-acetylglucosaminidase inhibitor | 0.167 0.046 DBMET00226 | DBMET00226 | |
| 0.051 | 0.173 | 0.1 | UDP-glucose 4-epimerase inhibitor | 0.1 0.061 DBMET00226 | DBMET00226 | |
| 0.007 | 0.129 | 0.023 | Kynurenine 3 monooxygenase inhibitor | 0.023 0.022 DBMET00226 | DBMET00226 | |
| 0.025 | 0.157 | 0.051 | Leukotriene C4 antagonist | 0.051 0.01 DBMET00226 | DBMET00226 | |
| 0.038 | 0.171 | 0.074 | Leukotriene C antagonist | 0.074 0.011 DBMET00226 | DBMET00226 | |
| 0.115 | 0.259 | 0.385 | Thyroid hormone beta antagonist | 0.385 0.058 DBMET00226 | DBMET00226 | |
| 0.063 | 0.215 | 0.119 | TRPA1 agonist | 0.119 0.06 DBMET00226 | DBMET00226 | |
| 0.111 | 0.266 | 0.387 | Thyroid hormone antagonist | 0.387 0.06 DBMET00226 | DBMET00226 | |
| 0.13 | 0.298 | 0.218 | DNA directed DNA polymerase inhibitor | 0.218 0.214 DBMET00226 | DBMET00226 | |
| 0.071 | 0.282 | 0.386 | Polo-like kinase-3 inhibitor | 0.386 0.004 DBMET00226 | DBMET00226 | |
| 0.096 | 0.311 | 0.304 | 12-Lipoxygenase inhibitor | 0.304 0.077 DBMET00226 | DBMET00226 | |
| 0.046 | 0.27 | 0.139 | Cytidine deaminase inhibitor | 0.139 0.083 DBMET00226 | DBMET00226 | |
| 0.012 | 0.24 | 0.115 | Bruton tyrosine kinase inhibitor | 0.115 0.012 DBMET00226 | DBMET00226 | |
| 0.09 | 0.327 | 0.284 | Transcription factor NF kappa B inhibitor | 0.284 0.104 DBMET00226 | DBMET00226 | |
| 0.005 | 0.253 | 0.05 | Carbonic anhydrase I inhibitor | 0.05 0.043 DBMET00226 | DBMET00226 | |
| 0.074 | 0.326 | 0.153 | Succinate dehydrogenase inhibitor | 0.153 0.107 DBMET00226 | DBMET00226 | |
| 0.11 | 0.382 | 0.206 | Histamine release inhibitor | 0.206 0.195 DBMET00226 | DBMET00226 | |
| 0.017 | 0.314 | 0.078 | MAP3K7 inhibitor | 0.078 0.042 DBMET00226 | DBMET00226 | |
| 0.032 | 0.331 | 0.126 | Alkaline phosphatase inhibitor | 0.126 0.079 DBMET00226 | DBMET00226 | |
| 0.006 | 0.344 | 0.033 | Catechol O-methyltransferase inhibitor | 0.033 0.022 DBMET00226 | DBMET00226 | |
| 0.015 | 0.429 | 0.039 | Cathepsin F inhibitor | 0.039 0.038 DBMET00226 | DBMET00226 | |
| 0.033 | 0.48 | 0.161 | Amyloid beta precursor protein antagonist | 0.161 0.09 DBMET00226 | DBMET00226 | |
| 0.024 | 0.478 | 0.086 | Thioredoxin inhibitor | 0.086 0.069 DBMET00226 | DBMET00226 | |
| 0.084 | 0.568 | 0.223 | Peptidyltransferase inhibitor | 0.223 0.073 DBMET00226 | DBMET00226 | |
| 0.014 | 0.576 | 0.146 | Epidermal growth factor receptor kinase inhibitor | 0.146 0.051 DBMET00226 | DBMET00226 | |
| 0.005 | 0.58 | 0.08 | HIV-1 integrase (3'-Processing) inhibitor | 0.08 0.034 DBMET00226 | DBMET00226 | |
| 0.007 | 0.649 | 0.085 | Leukotriene synthesis inhibitor | 0.085 0.034 DBMET00226 | DBMET00226 | |
| 0.07 | 0.727 | 0.312 | ErbB-1 antagonist | 0.312 0.03 DBMET00226 | DBMET00226 | |
| 0.004 | 0.718 | 0.086 | HIV-1 integrase (Strand Transfer) inhibitor | 0.086 0.028 DBMET00226 | DBMET00226 | |
| 0.005 | 0.8 | 0.071 | HIV-1 integrase inhibitor | 0.071 0.047 DBMET00226 | DBMET00226 | |
| 0.013 | 0.863 | 0.283 | Apoptosis agonist | 0.283 0.185 DBMET00226 | DBMET00226 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |